Integrating Non-Invasive Biomarkers to Allow for Earlier Intervention in Treating Neurodegenerative Disease
Time: 8:00 am
day: Blood-Based Biomarker Focus Day
Details:
- The hallmarks of Alzheimer’s Disease require a multimodal approach of biomarkers to evaluate heterogeneity of disease
- Non-invasive biomarker modalities for diagnosis, staging and treatment response
- Enabling a personalized approach using global proteomics and molecular subtyping to reflect disease heterogeneity
